Vaxcyte, Inc. (NASDAQ:PCVX) Receives $147.50 Average PT from Analysts
Shares of Vaxcyte, Inc. (NASDAQ:PCVX – Get Free Report) have been given an average rating of “Buy” by the nine research firms that are currently covering the company, Marketbeat Ratings reports. Nine analysts have rated the stock with a buy recommendation. The average 12-month target price among brokers that have updated their coverage on the […]
Shares of Vaxcyte, Inc. (NASDAQ:PCVX – Get Free Report) have been given an average rating of “Buy” by the nine research firms that are currently covering the company, Marketbeat Ratings reports. Nine analysts have rated the stock with a buy recommendation. The average 12-month target price among brokers that have updated their coverage on the […]
